Latest News for: wize

Edit

Choroideremia Treatment Market Current Trends Analysis with Growth Segments, Industry Size and Share Forecast to 2021-2028 | Copernicus Therapeutics, Wize Pharma, F. Hoffmann-La Roche Ltd

Pharmiweb 22 Jul 2021
 Biogen 4D MOLECULAR THERAPEUTICS Novartis AG Spark Therapeutics, Inc bluebird bio, Inc Copernicus Therapeutics, Inc Wize Pharma Inc F ... 4D MOLECULAR THERAPEUTICS, Novartis AG, Spark Therapeutics, Inc., bluebird bio, Inc., Copernicus Therapeutics, Inc., Wize Pharma Inc., F.
Edit

Ottawa edtech startup EssayJack acquired by Vancouver’s Wize

Ottawa Business Journal 21 Jul 2021
An Ottawa-based startup that’s helped more than 30,000 students complete essays, book reports and speeches is preparing to write a new chapter of its own after being acquired by Vancouver online learning platform Wize ... “This pandemic has changed education,” said Ledohowski – who will join Wize as vice-president of operations – in a statement.
Edit

Wize tosses seven shutout frames in Moo win

Fremont Tribune 09 Jun 2021
Seven shutout innings from Alex Wize helped propel the Fremont Moo to their 11th straight victory in a 4-1 win over the Hastings Sodbusters Tuesday night at Moller Field. Wize (1-0) threw seven shutout innings, allowing just five hits and no walks while striking out four.
Edit

Wize Pharma to change name to Mawson Infrastructure Group Inc.

Daily Freeman 24 Mar 2021
SYDNEY, March 24, 2021 /PRNewswire/ -- Wize Pharma Inc. (OTCQB ... James Manning, CEO of Mawson Infrastructure, said. "Sir Douglas Mawson was an Australian hero – an explorer, geologist and academic, as well as a key expedition leader in the heroic age of Antarctic exploration ... About Mawson Infrastructure ... Or Eisenberg ... SOURCE Wize Pharma, Inc ... ....
Edit

Clint on Immunize Wizely with Ingri Cassel

Bitchute 17 Mar 2021
Go to the source via the link below to view the video..
Edit

Wize Pharma set for switch to Bitcoin mining

Globes 17 Feb 2021
Wize Pharma has spun off its ophthalmology drug development activities, and will begin to mine digital currencies in another month through Cosmos.
Edit

Wize Pharma's Takeover Offer for Cosmos Capital Declared Unconditional

Daily Freeman 16 Feb 2021
Wize strongly encourages all remaining Cosmos shareholders to accept the Offer ... About Wize Pharma. Wize Pharma, Inc ... Offer for ordinary shares by Wize Pharma, Inc ... Wize Pharma, Inc (Wize) has made offers under an off-market takeover bid (Offers) for all of the ordinary shares in Cosmos Capital Limited ACN 636 458 912 (Cosmos) ... SOURCE Wize Pharma, Inc.
Edit

X-tend Robotics Inc. Enters Into Long Term License Agreement With WIZE DSP Lt.

MENA FN 06 Feb 2021
(MENAFN - EIN Presswire) The M1 Medi-Corp Care Giver Robot Agreement would allow X-Tend to integrate WIZE DSP's noise eliminating tech into the comp... .
Edit

EdTech Startup Wize Raises US$3 Million to Enhance the Online Learning Experience for Students

Idaho State Journal 28 Jan 2021
Delivery of highly tailored course content prevents learning loss due to COVID-19 and helps students realize their personal potential ... .
Edit

Wize Pharma Receives Bonus BioGroup Shares from Escrow and Additional Bonus BioGroup Shares Totaling $1.3 Million USA - English USA - English

PR Newswire 04 Jan 2021
4, 2021 /PRNewswire/ -- Wize Pharma, Inc ... According to the Addendum, Wize has agreed to amend certain provisions in the original transaction, including waiving the Nasdaq Milestone, such that the Bonus shares and funds were released from escrow to Wize and Bonus, respectively ... About Wize Pharma. Wize Pharma, Inc ... SOURCE Wize Pharma, Inc.
Edit

Wize Pharma merges with Australian Bitcoin miner Cosmos

Globes 01 Jan 2021
Israeli clinical stage biopharmaceutical company Wize Pharma Inc ... leave Cosmos's shareholders owning most of Wize's shares.
Edit

Wize Pharma and Cosmos Capital enter into Bid Implementation Agreement USA - English USA - English

PR Newswire 30 Dec 2020
30, 2020 /PRNewswire/ -- Wize Pharma, Inc ... Wize Pharma Logo ... "We are excited about the Wize Cosmos transaction," stated Noam Danenberg, CEO of Wize ... Upon completion of the transaction, pre-closing Wize securityholders will receive one contingent value right ("CVR") for each share of Wize held on the record date ... About Wize Pharma.
Edit

Choroideremia Treatment Market Forecast Analysis 2020-2026: Biogen, 4D Molecular Therapeutics, Copernicus Therapeutics, Inc, Wize Pharma Inc, Spark Therapeutics, Inc, PIXIUM VISION

Pharmiweb 19 Oct 2020
Some of the major competitors currently working in the global choroideremia treatment market are Biogen, 4D Molecular Therapeutics, Copernicus Therapeutics, Inc, Wize Pharma Inc, Spark Therapeutics, Inc, PIXIUM VISION, Retina Implant AG, F. Hoffmann-La Roche Ltd and others. Market Definition... According to the statistics published by U.S ... .

Most Viewed

×